|
|
CET Details
CET Summary
| CET Name : |
Age related Macular Degeneration |
|---|
| Target Group : |
Optometrists
Dispensing Opticians |
|---|
| Standard of CET : |
Not Set |
|---|
| Short CET Abstract : |
Age Related Macular Degeneration
A lecture updating practitioners on ARMD and fast track referral by optometrists |
|---|
| CET Duration / Length : |
2 Learning Hours |
|---|
| Number Of Points : |
2.00 |
|---|
| Points Type : |
general |
|---|
| CET Cost : |
met by Novartis |
|---|
Further Details
| Learning Objectives : |
Age Related Macular Degeneration -Grand round!
An update on the differences between wet and dry Age Related Macular Degeneration, the signs & symptoms relating to each type. suitability for referral, and when referral is appropriate.
Lucentis-what it is and how to get it?
Current treatments, the results of completed and on-going research. Introduction the new Rapid Access Referral Form to be used by Optometrists who have attended these sessions and information on sites who hold a contract with PCTs |
|---|
| Author Short CV(s) : |
MANJU CHANDRAN
GMC REGISTRATION No : 6154716
QUALIFICATION AWARDING BODY YEAR
MRCOphth Royal College of Ophthalmologists, London 2007
D.N.B National Board of Examinations, New Delhi 1997
D.O. Mahatma Gandhi University, Kerala, India 1995
M.B.B.S University of Calicut, Kerala, India 1992
POSITIONS HELD:
Current Position
Associate specialist In Department of Ophthalmology ,Frimley Park Hospital, Portsmouth Road, Camberley, Surrey , GU!6 7UJ , United Kingdom from 01-04-09
Designation Hospital From To
Staff grade Frimley Park hospital Apr 08 Apr 09
Research Fellow Frimley Park Hospital, Jun 07 Mar 08
Junior Consultant Lourdes Hospital, Mar 97 Aug 05
Ophthalmology Cochin 682012, India
Junior Resident Little Flower Hospital Jan 95 Feb 97
Ophthalmology Angamaly.India
During the period between 31-08-05 to 14-06-07 I was writing the Royal College of Ophthalmologist’s exam.
Professional Memberships:
1. Royal College of Ophthalmologists, London.
2. The Association for Research in Vision and Ophthalmology ( ARVO)
3. The Kerala State Ophthalmological Society
4 All India Ophthalmogical Society
RESEARCH
Clinical trials
I have been a sub investigator for the following trials
A randomised controlled trial of alternative treatments to inhibit VEGF in age-related choroidal neovascularisation (IVAN Trial)
Randomised controlled trial assessing the efficacy of Pegaptabnib sodium in the prevention of proliferative diabetic retinopathy
A phase II prospective , randomised, multicenter Diabetic macular oedema dose ranging, comparator study evaluating the efficacy and safety of PF-04523655 versus laser therapy ( DEGAS Trial)
A randomized, doublemasked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trap-Eye in subjects with neovascular AMD (VIEW 2 )
Prevention of pseudophakic cystoid macular oedema with pre- and postoperative topical ketorolac drops (ketorolac trial)
Randomised control study of Bevacizumab in the treatment of occult and minimally classic choroidal neovascularisation. (BeMOC Trial)
Randomised control study of combined photodynamic treatment and Ranibizumab versus Ranibizumab mono therapy ( Mont Blanc Trial)
A randomised multicenter, laser controlled Phase III study assessing the efficacy and safety of Ranibizumab as adjunctive and monotherapy in patients with visual impairement due to diabetic macular edema ( Restore Trial)
A 3 year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System ( DEX PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema (Posurdex trial)
AUDITS
The treatment of patients with proliferative diabetic retinopathy and macular oedema: Are we adhering to time frame guidelines 2009
Abstracts
M. N. Chandran, A. Venkat, R. Shah, D. Mathapati, G. Ansari, L. North, N. Sangha, S. Sivaprasad, and G. Menon
A Randomised Controlled Trial Comparing the Two Protocols of Treatment of Intravitreal Bevacizumab for Neovascular Age Related Macular Degeneration (Bemoc Trial)
Invest. Ophthalmol. Vis. Sci. 2009 50: E-Abstract 5222.
D. Mathapati, M. Chandran, A. Venkataramaiah, G. Ansari, J. Jarzabek, L. North, B. Mathapati, N. Sangha, and G. Menon
An Optical Coherence Tomography Guided Loading Dose Treatment With Intravitreal Ranibizumab for Neovascular Age Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci. 2009 50: E-Abstract 2376.
Outcome of intravitreal Ranibizumab in patients with age related macular degeneration and low visual acuity
R Shah, M damani, W Tucker, L barker,L North, D Mathapati, M Chandran, G Menon
N. Minakaran, L. Barker, M. Chandran, G. Ansari, D. Mathapati, L. North, B. Mathapati, and G. Menon
Predictors of Efficacy of Intravitreal Ranibizumab for Choroidal Neovascularisation Secondary to Age-Related Macular Degeneration: First Eye Affected vs Second Eye Affected
Invest. Ophthalmol. Vis. Sci. 2009 50: E-Abstract 968.
G. Ansari, M. Chandran, D. Mathapati, S. Pilli, S. Patil, J. Jarzabeck, and G. Menon
Intravitreal Bevacizumab For Choroidal Neovascularization Previously Treated With Photodynamic Therapy
Invest. Ophthalmol. Vis. Sci. 2008 49: E-Abstract 324
M. N. Chandran, D. Mathapati, S. Pilli, S. Patil, L. North, G. Ansari, and G. Menon
Comparison of Efficacy of Bevacizumab and Ranibizumab in the Treatment of Occult Choroidal Neovascular Membrane in Age Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci. 2008 49: E-Abstract 325.
S. Patil, S. Pilli, D. Mathapati, M. Chandran, G. Ansari, S. Mackenzie, J. Jarzabek, and G. Menon
Role of Intravitreal Bevacizumab (Avastin) in the Management of Peripapillary Choroidal Neovascular Membrane
Invest. Ophthalmol. Vis. Sci. 2008 49: E-Abstract 328.
Randomised Controlled Trial on the Dosing Schedule of Intravitreal Bevacizumab injections in the Management of Occult and Minimally Classic Choroidal Neovascular Membrane (CNV) Secondary to Age-Related Macular Degeneration (AMD), Poster presentation at AAO and SOE joint meeting, Atlanta, November 2008 D Mathapati, M Chandran, S Pilli, E pringle, S Shivaprasad, G Menon
MANAGEMENT
Deputy head of Clinical trials Unit
Department representative for clinical audits committee
Department representative for consent committee
Member of UK Comprehensive Local Research Network
|
|---|
Assessment Methods and Facilities
| Modality : |
Lecture |
|---|
| Closing Date (if applicable) : |
29-Jul-2010 |
|---|
| Self-Assessment Method : |
Submission Of Short Answers |
|---|
| Evidence of Completion : |
Simple Signed And Dated Certificate |
|---|
| Feedback Collection Method : |
Course Feedback Sheet |
|---|
| Special Facilities / Equipment : |
OHP
OHP |
|---|
Other Information
| Internal CET Reference : |
AMD-16.03.10 |
|---|
| Competencies Covered : |
Communication Skills for Optometrists
Ocular Abnormalities for Optometrists
Communication Skills for Dispensing Opticians
Ocular Abnormalities for Dispensing Opticians |
|---|
| Any Other Information : |
|
|---|
|
|
|
